Abstract Non Muscle Invasive Bladder Cancer (NMIBC) is among the most frequent
malignant cancers worldwide. NMIBC is treated by transurethral resection of the bladder …

Background: Clinical outcomes of bladder cancer (BC) are tightly associated with the stage
and grade of the initial diagnosis of BC because early detection is clearly important for …

Purpose Bladder cancer (BC) is among the most frequent malignancies worldwide. Novel
non-invasive markers are needed to diagnose and stage BC with more accuracy than …

Bladder cancer (BC) is a common urological malignancy with a high probability of death and
recurrence. Cystoscopy is used as a routine examination for diagnosis and following patient …

Bladder cancer (BC) is a common cancer but diagnostic modalities, such as cystoscopy and
urinary cytology, have limitations. Here, high-performance liquid chromatography …

Patients with non-muscle invasive bladder cancer (NMIBC) undergo lifelong monitoring
based on repeated cystoscopy and urinary cytology due to the high recurrence rate of this …

Purpose Bladder cancer is one of the most common malignancies of the urinary system, and
its screening relies heavily on invasive cystoscopy, which increases the risk of urethral injury …

Bladder cancer (BCa) is ninth amongst the most common types of cancer in the human
population worldwide. The statistics of incidence and mortality of BCa are alarming and the …

The incidence and rate of recurrence of bladder cancer is high, particularly in developed
countries, however current methods for diagnosis are limited to detecting high-grade …

Bladder cancer (BC) is one of the most frequent cancer in the world, and its incidence is
rising worldwide, especially in developed countries. Urine metabolomics is a powerful …